Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Follistatin-344 for Body Composition: Research Source Comparison

Before selecting a Follistatin-344 source, researchers must evaluate synthesis quality, purity verification, and post-synthesis handling. The comparison below highlights what separates research-grade suppliers from bulk manufacturers. Synthesis Method Small-ba

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before selecting a Follistatin-344 source, researchers must evaluate synthesis quality, purity verification, and post-synthesis handling. The comparison below highlights what separates research-grade suppliers from bulk manufacturers.
  • Synthesis Method
  • Small-batch SPPS with fragment condensation, verified amino acid sequencing
  • Large-batch automated synthesis, sequence verification optional
  • Small-batch synthesis reduces coupling errors that cause deletion sequences. Critical for 323-residue peptides like Follistatin-344
  • Purity Verification
  • ≥98% by HPLC + mass spectrometry confirmation + endotoxin testing on every batch
  • HPLC purity reported (often 85–95%), mass spec and endotoxin testing inconsistent
  • Mass spec catches sequence errors HPLC misses; endotoxin levels above 1.0 EU/mg trigger inflammatory responses that confound research outcomes
  • Lyophilization Protocol
  • Freeze-dried with mannitol or trehalose cryoprotectants to preserve tertiary structure
  • Lyophilized without excipients or with non-protective fillers
  • Peptides lyophilized without cryoprotectants undergo conformational changes during freeze-thaw, reducing receptor binding affinity by 40–60%
  • Certificate of Analysis
  • Batch-specific CoA with purity %, molecular weight, endotoxin levels, and storage recommendations
  • Generic CoA or no documentation provided
  • Batch-specific CoAs allow researchers to verify structural integrity before use. Essential for reproducible results
  • Cold Chain Management
  • Shipped with gel packs in insulated packaging, temperature monitoring recommended
  • Shipped at ambient temperature or with minimal insulation
  • Temperature excursions above 25°C during shipping cause irreversible peptide aggregation; cold chain integrity is non-negotiable
  • Reconstitution Guidance
  • Detailed reconstitution protocol, bacteriostatic water volume recommendations, storage duration
  • Minimal or no reconstitution instructions provided
  • Incorrect reconstitution (wrong diluent, excessive agitation, improper storage) is the leading cause of peptide degradation post-purchase